Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) Short Interest Update

Coloplast A/S Sponsored ADR (OTCMKTS:CLPBY) saw a significant decline in short interest in the month of May. As of May 29th, there was short interest totaling 225,427 shares, a decline of 45.5% from the May 14th total of 413,714 shares. Based on an average trading volume of 760,388 shares, the short-interest ratio is currently 0.3 days. Currently, 0.0% of the shares of the company are short sold.

Coloplast A/S Stock Performance

OTCMKTS CLPBY opened at $5.99 on Friday. The company has a market capitalization of $13.50 billion, a price-to-earnings ratio of 42.79, a PEG ratio of 1.90 and a beta of 0.18. Coloplast A/S has a twelve month low of $5.83 and a twelve month high of $10.03. The stock has a fifty day simple moving average of $6.38 and a 200 day simple moving average of $7.49. The company has a quick ratio of 0.81, a current ratio of 1.30 and a debt-to-equity ratio of 1.50.

Coloplast A/S (OTCMKTS:CLPBY) last posted its quarterly earnings data on Tuesday, May 12th. The company reported $0.10 earnings per share for the quarter, topping the consensus estimate of $0.09 by $0.01. The firm had revenue of $1.11 billion during the quarter, compared to analyst estimates of $1.11 billion. Coloplast A/S had a return on equity of 31.96% and a net margin of 7.46%. Sell-side analysts expect that Coloplast A/S will post 0.4 EPS for the current year.

Wall Street Analyst Weigh In

Several brokerages recently issued reports on CLPBY. Kepler Capital Markets upgraded Coloplast A/S to a “strong-buy” rating in a research note on Wednesday, May 20th. The Goldman Sachs Group cut Coloplast A/S from a “hold” rating to a “strong sell” rating in a research note on Tuesday, April 7th. One analyst has rated the stock with a Strong Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold”.

About Coloplast A/S

Coloplast A/S is a global developer and manufacturer of medical devices and services focused on intimate healthcare. The company specializes in solutions designed to assist individuals with chronic medical conditions, aiming to improve quality of life through innovative products. Coloplast’s offerings span ostomy care, continence care, wound and skin care, and interventional urology, targeting patients who require long-term support and specialized treatments.

In its ostomy business, Coloplast provides pouches, skin barriers and accessories for patients who have had surgical procedures to divert bodily waste.